Related Experiment Video
Updated: Dec 25, 2025

Following Cell-fate in E. coli After Infection by Phage Lambda
Published on: October 14, 2011
Characterization of the Enterobacter Phage vB_EclM_CIP9
Klara Wang1,2, Marielou G Tamayo1, Tiffany V Penner2
1Cytophage Technologies, Inc., Winnipeg, Manitoba, Canada.
Abstract:
Enterobacter cloacae is an opportunistic pathogen that causes hospital-acquired infections in immunocompromised patients. Here, we describe vB_EclM_CIP9, a novel Enterobacter phage that infects a multidrug-resistant isolate of E. cloacae Phage vB_EclM_CIP9 is a myovirus that has a 174,924-bp genome, with 296 predicted open reading frames.
Insights
A new bacteriophage, vB_EclM_CIP9, has been identified that targets multidrug-resistant Enterobacter cloacae. This discovery offers a potential new strategy for combating hospital-acquired infections caused by this opportunistic pathogen.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Enterobacter cloacae is an opportunistic pathogen responsible for hospital-acquired infections, particularly in immunocompromised individuals.
- The rise of multidrug-resistant (MDR) bacterial strains poses a significant threat to public health, complicating treatment options.
Purpose of the Study:
- To describe a novel bacteriophage, vB_EclM_CIP9, with the capacity to infect and potentially control MDR Enterobacter cloacae.
- To characterize the genomic and morphological features of the newly discovered phage.
Main Methods:
- Isolation and characterization of bacteriophage vB_EclM_CIP9 from environmental samples.
- Genomic sequencing and analysis of the bacteriophage.
- Identification of predicted open reading frames within the phage genome.
Main Results:
- Discovery of vB_EclM_CIP9, a novel myovirus bacteriophage.
- vB_EclM_CIP9 infects a multidrug-resistant isolate of Enterobacter cloacae.
- The phage possesses a large genome of 174,924 base pairs with 296 predicted open reading frames.
Conclusions:
- Bacteriophage vB_EclM_CIP9 represents a promising candidate for phage therapy against MDR Enterobacter cloacae infections.
- Further research into the lytic activity and host range of vB_EclM_CIP9 is warranted.
Related Concept Videos
Viral Replication: Lytic Cycle
DNA Bacteriophages
Lytic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Lysogenic Cycle of Bacteriophages

